Get Answers

What do I need to know if I am planning for surgery and I have lupus?

If I have a fungal infection, are all anti-fungals safe for me to take?

Is it safe to take Lamisil® (terbinafine hydrochloride) and other antifungal treatments?

Do vaccines cause lupus flares?

What seasonal allergy medicines can I take?

Are there any birth control methods that should be avoided if I have lupus?

What types of birth control can I use if I have lupus?

What is drug induced lupus?

Will my child’s vision health be affected by lupus treatments?

What medications are available to treat symptoms of lupus in children?

What do I need to know about Benlysta®?

How is lupus treated?

What do I need to know about Rituxan® and lupus?

Which medications and herbal supplements should be avoided by people with lupus?

What do I need to know about the hormone therapy Premarin® and lupus?

Should people with lupus avoid the drugs associated with drug-induced lupus?

How quickly does drug-induced lupus develop?

Which medications cause drug-induced lupus?

What do I need to know about corticosteroids and side effects?

What do I need to know about beta-blocker medications and lupus?

Can long-term use of prednisone cause diabetes?

What do I need to know about drinking alcohol and taking Plaquenil®?

What do I need to know about taking blood pressure medications and lupus?

Are there effective medications for lupus beside prednisone?

What treatments are being studied for lupus?

How can traveling be made easier?

What is the best approach to taking medications?

What medications are used to treat lupus?

Can I still plan a pregnancy?

What is the best way to deal with my pain?


News & Stories

Research News | Jul. 31, 2014

Mixed Results for Phase II Clinical Study of Atacicept in Lupus

Flare rates among participants receiving a low dose of the b-cell blocker did not meet primary endpoint but were lower for individuals receiving a higher dose.

Magazine | May. 11, 2014

Vision Quest

Learn how you can be proactive about protecting your sight

Research News | Feb. 04, 2014

Pilot Study Testing a Combination of Immunosuppressive Drugs Holds Promise for Children with Lupus

Results from a small pilot study provide hope that lupus disease activity can be suppressed in children with lupus. Read more.

Blog | Dec. 04, 2013

Access to Prescription Drugs is a Must

Kim Cantor, Lupus Foundation of America’s Senior Director of Public Policy and Government Relations, discusses the Foundation’s Medicare for Patients RX (MAPRx) Coalition

Podcasts | Nov. 13, 2013

Biomarkers of Lupus Disease: Eliminating the Perplexities of Lupus Treatment Trials

Lupus Foundation of America medical director Dr. Joan Merrill discusses a recently completed a study that may help to improve the design for future lupus clinical trials and secure approval of new safe and more tolerable treatments for lupus.

Blog | Nov. 05, 2013

Why Are Treatments That Were Developed For Malaria Now Widely Used for Lupus?

In her Expert Column, Dr. Joan T. Merrill, Medical Director, explains why antimalarial medicines are now used to treat lupus.

Podcasts | Nov. 04, 2013

Complementary Medicine and Lupus

Ask the Expert: Dr. Betsy Blazek O'Neill discusses complementary medicines and lupus

Research News | Oct. 28, 2013

New Findings Show Damage Resulting from Lupus is a Potentially Modifiable Outcome

According to research presented this week at the American College of Rheumatology Annual Meeting, researchers have identified three potentially modifiable risk factors and one protective medication that may improve the health of people living with lupus.

Research News | Oct. 28, 2013

In Treatment Adherence Study, Many Medicaid Beneficiaries Struggled to Stay on Medications

Researchers from the University of California and Brigham and Women’s Hospital in Boston recently examined adherence among Medicaid beneficiaries with lupus to prescribed medications and found the patients were not following treatment plans, putting themselves at risk for poor outcomes.

General News | Sep. 28, 2013

Learn About the New Health Insurance Marketplace

The Health Insurance Marketplace offers coverage to many Americans who currently do not have health insurance. We have gathered relevant links to help you locate the information you need to know.

General News | Sep. 11, 2013

The Lupus Foundation of America Helps Pave the Way for Access to Future Lupus Treatments

New study reinforces need for Patients’ Access to Treatments Act (H.R. 460) to reduce excessive financial burden placed on people with chronic diseases

Research News | Jun. 03, 2013

Early Use of Hydroxychloroquine May Protect Against Organ Damage in Lupus

People with lupus who were treated with hydroxychloroquine (HCQ), an anti-malarial drug, early after a diagnosis of lupus had less cumulative organ damage at three years after diagnosis than those who did not receive HCQ, according to a new analysis.

Magazine | Mar. 01, 2013

Access to Care: What is Being Done, and for Whom?

After more than a half-century of drought, many new treatments are in development for lupus. However, approval of a new treatment does not ensure that all people with lupus will be able to try it.

Research News | Jan. 10, 2013

Study explores lupus treatments and disease activity as risk factors for lymphoma

A new study sheds light on the specific effects of drug treatments versus disease activity as risk factors for lymphoma, a type of cancer, among people with lupus.

Video | Nov. 08, 2012

Advancing Science - Improving Lives

Our national lupus research program aggressively seeks to advance the science and medicine of lupus and to improve the quality of life for all people affected by lupus.

Research News | Nov. 08, 2012

Steroid-Related Risk of Heart Disease in Lupus

The results of this study indicate that current use of steroids (20 mg/day or more) is perhaps the most significant risk factor for heart disease in individuals with lupus.

General News | Oct. 04, 2012

People With Lupus Deserve Access to Full Range of Medications Under Affordable Care Act

The Lupus Foundation of America is calling on the Department of Health and Human Services to ensure that people with chronic diseases get access to medications.

Podcasts | Sep. 20, 2012

New Therapeutic Approaches in Lupus

Dr. Murray Urowitz discusses current and potential new therapies for managing lupus.

Research News | Sep. 18, 2012

Rontalizumab: A Potential New Lupus Therapy

Rontalizumab is a potential new drug to treat lupus. It reduces the effects of the excessive interferon-alpha that is so characteristic of lupus. The researchers hoped to learn about the safety and tolerability of rontalizumab in people with mild lupus disease activity.

Research News | Aug. 15, 2012

Short-Term Use of Hydroxychloroquine Reduces Cholesterol in Lupus

People with lupus are at increased risk of cardiovascular disease, especially when taking steroids. The use of anti-malarial drugs, such as hydroxychloroquine, significantly reduces this risk.

Research News | Jul. 17, 2012

Long-Term Safety of Benlysta®

This study examined the long-term safety of belimumab over a 4-year period in people with lupus. The results highlight the long-term safety of belimumab over a 4-year period.

Magazine | Jul. 01, 2012

Weather Tips for Medication Safety

If your luggage is exposed to extreme temperatures or humidity, your medications could lose potency and effectiveness.

Podcasts | May. 22, 2012

Treating Lupus

Dr. Richard Furie of the North Shore-Long Island Jewish Health System provides an overview of how lupus is treated.

Podcasts | Apr. 30, 2012

Understanding Lupus

Lupus Foundation of America Medical Director Dr. Joan Merrill provides an overview of lupus and its health effects.

Research News | Mar. 22, 2012

Lupus Biomarker Changes Key to Benlysta Therapy

The findings highlight specific kinds of changes in lupus biomarkers that are most associated with effective use of belimumab in the treatment of lupus.

Research News | Jan. 20, 2012

First Ever Study of Cholesterol-Lowering Drugs in Children With Lupus

The researchers hoped to learn about the safety and efficacy of atorvastatin (Lipitor®) in reducing cholesterol in children with lupus.

General News | Nov. 16, 2011

New England Journal of Medicine Publishes Results of Study of CellCept® for Lupus Nephritis

The New England Journal of Medicine published results from a long-term study for the treatment of lupus nephritis.

Podcasts | Nov. 16, 2011

Developing Consensus Treatment Plans for Pediatric Lupus Nephritis

Dr. Emily von Scheven of the University of California at San Francisco discusses the development of consensus treatment plans for proliferative nephritis in juvenile systemic lupus.

Podcasts | Nov. 16, 2011

Vitamin D Supplementation in Lupus

Dr. Michelle Petri of the Johns Hopkins University Medical Center discussed the results of a study of vitamin D supplementation in people with lupus.

General News | Oct. 31, 2011

Lupus Organizations Around the Globe Urge NICE to Provide Coverage for Benlysta®

National lupus organizations, and individuals with lupus and their families around the world, are rallying to protect access to new treatments of lupus.

General News | Jul. 13, 2011

Health Canada and European Medicines Agency Approves BENLYSTA™

Health Canada and European Regulators have approved BENLYSTA™.

Magazine | Jul. 01, 2011

You and Your Doctor: Why Do Medications Seem to Stop Working?

Don’t make your lupus worse by ignoring your doctor’s instructions—take your medications as prescribed. And if there is some reason you aren’t taking them, talk to your doctor or pharmacist. Help them to help you!

Magazine | Jul. 01, 2011

Path to Progress

The approval of Benlysta—the first lupus drug in more than 50 years—ushers in a new era of treatment.

General News | May. 20, 2011

European Review Board Issues Positive Opinion for Benlysta®

The European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive opinion, recommending marketing authorisation for BENLYSTA®.

General News | Mar. 09, 2011

LFA Applauds FDA Decision to Approve Benlysta for the Treatment of Lupus

The U.S. Food and Drug Administration (FDA) approved the drug, BENLYSTA®, for the treatment of lupus, an autoimmune disease.

General News | Feb. 08, 2011

Human Genome Sciences and GlaxoSmithKline Announce Publication Phase 3 Study Results for BENLYSTA®

Human Genome Sciences and GlaxoSmithKline announced publication of the BLISS-52 study of BENLYSTA®.

Research News | Jan. 07, 2011

Epratuzumab is Safe and Effective for Treatment of Lupus in Phase II Trials

Epratuzumab is an investigational agent for the treatment of lupus. The researchers hoped to learn whether epratuzumab could be a safe and effective treatment for people with moderate-to-severe lupus.

Research News | Jan. 07, 2011

CellCept® Is Superior to Azathioprine In Treatment of Lupus Nephritis

There are a number of treatments used for lupus nephritis, but none of them are approved by the U.S. Food and Drug Administration (FDA). The researchers hoped to compare the efficacy and safety of MMF and azathioprine as maintenance therapy.

Research News | Jan. 07, 2011

Belimumab Allows For Reduction in Steroid Use for People with Lupus

The researchers hoped to learn whether treatment with belimumab could reduce the use of steroids in people with active lupus.

Research News | Nov. 04, 2010

Use of Hydroxychloroquine Benefits Sugar Metabolism in Women With Lupus

The researchers hoped to learn whether there are any tests that could predict low blood sugar in women with lupus taking hydroxychloroquine.

Magazine | Nov. 01, 2010

About Time: Get the Most Out of Your Meds

Keeping track of your medications, and taking them correctly, can feel overwhelming. Learn more about how to get the most out of your medications.

Video | Oct. 28, 2010

New Therapeutic Targets for Lupus

Dr. Isenberg discusses several of the new agents under evaluation for lupus and looks to ways lupus treatment will change with evolving technology and new scientific findings.

Research News | Aug. 18, 2010

Hydroxycholoroquine May Protect Against Skin Involvement in Lupus

The researchers hoped to learn what factors have an impact on how much time it takes for a lupus patient to develop skin damage.

Research News | Aug. 18, 2010

Anti-malarial Drugs Decrease Risk of Blood Clots in People with Lupus

The researchers hoped to determine the risk of developing blood clots in people with lupus, while factoring in the year of diagnosis and disease severity.

Research News | Jul. 20, 2010

Successful Phase III Trial of CellCept® for Lupus Nephritis

The researchers wanted to compare the effectiveness of mycophenolate mofetil (CellCept) with that of azathioprine to prevent kidney flares after the initial treatment for nephritis was successful.

Research News | Jul. 20, 2010

Belimumab Reduces Lupus Disease Activity After 76 Weeks

The researchers hoped to learn about the safety and potential effectiveness of belimumab in the treatment of lupus.

Magazine | Jul. 01, 2010

Drug Spotlight on Hydroxychloroquine

Hydroxychloroquine belongs to the family of medicines called “antimalarials” (AMs), which are also classified as disease-modifying anti-rheumatic drugs, or DMARDs. These drugs were initially used to prevent and to treat malaria but are no longer used for those purposes.

Podcasts | May. 27, 2010

Newly Diagnosed with Lupus

Dr. David Wofsy of the University of California, San Francisco, leads a discussion and takes questions about being newly diagnosed and living with lupus.

Research News | Dec. 22, 2009

Genentech’s Rontalizumab Is Well-Tolerated by Lupus Patients in a Phase I Clinical Trial

This trial was the first stage of testing for rontalizumab, which is a new treatment that interferes with an inflammatory protein called "interferon-alpha."


Events

Nov. 13, 2014 7:00 pm | Teleconference

Ask The Experts: Lupus and Stress

Learn how to reduce and cope with stress.

Oct. 18, 2014 10:00 am | Teleconference

Ask The Experts: Lupus and Disability

What you need to know to help with issues surrounding disability.

Apr. 17, 2014 5:00 pm

SLESH Course

Join us for the SLE Self Help Course - a five week program designed to teach people with lupus how to take a more active part in their health care and live better despite lupus.

Dec. 06, 2014 10:00 am | Broward College (North Campus)

Redefining Lupus : Putting the Pieces Together (South Florida- Broward)

Join us for the only lupus educational seminar series in Florida. This comprehensive event will cover a variety of topics and the latest lupus advancements.

Oct. 25, 2014 10:00 am | Palm Beach Atlantic University

Redefining Lupus : Putting the Pieces Together (South Florida- Palm Beach)

Join us for the only lupus educational seminar series in Florida. This comprehensive event will cover a variety of topics and the latest lupus advancements.

Sep. 06, 2014 10:00 am | Florida State College (Kent Campus)

Redefining Lupus: Putting the Pieces Together (Northern Florida)

Join us for the only lupus educational seminar series in Florida. This comprehensive event will cover a variety of topics and the latest lupus advancements.

Oct. 18, 2014 9:00 am | Continental Room - Central Connecticut State University

Life & Lupus Educational Symposium

Come out for our Life & Lupus Educational Symposium, featuring medical and alternative health professionals.

Sep. 06, 2014 10:00 am | Myers Park Presbyterian Church Outreach Center

Charlotte Lupus Empowerment Seminar

This seminar will provide information on 2 different topics: Lupus and the Musculoskeletal System and Complementary and Alternative Medicine.

Jun. 28, 2014 9:00 am | Meeting will take place at Overlook Hospital, Summit, New Jersey

Annual Business Meeting

Meeting Agenda: Opening Remarks, Educational Seminar, Board Elections, Cathy Lee Iczkowski Service Award, Butterfly of Hope Recognition Awards, Walk Award Presentations, Volunteer Recognition Awards, Closing Remarks.

May. 31, 2014 10:00 am | Washington, DC

Understanding Advocacy- How You Can Help!

Feel empowered to advocate for yourself on a social and political level to overcome healthcare barriers.

Mar. 15, 2014 9:30 am | Corporate University in the Dowdle Center on the Huntsville Hospital Campus

Living with Lupus Seminar

The Mid-South Chapter is presenting its first "Living with Lupus" seminar in Huntsville, AL on Saturday, March 15, 2014. Dr. Winn Chatham will be presenting the topic, "Current & Promising New Approaches to Treating Lupus".

Mar. 22, 2014 1:00 pm

Augusta Lupus Empowerment Symposium

Our Annual Lupus Symposium in Augusta has moved to March 22, 2014!

Aug. 21, 2013 6:00 pm | Broadlawns Medical Center

Support Group

Sep. 21, 2013 9:00 am | Kansas City

Kansas City Behind the Mask Education Conference

Questions about coping with Lupus? Sign up today!